Animal models for bladder cancer: The model establishment and evaluation (Review)

Oncology Letters
Ning ZhangXiang Wang

Abstract

Bladder cancer is the most common type of tumor in the urogenital system. Approximately 75% of patients with bladder cancer present with non-muscle-invasive cancer, which is generally treated by transurethral resection and intravesical chemotherapy. In spite of different therapeutic options, there remains a very variable risk of recurrence and progression. Novel therapeutic methods of treating bladder cancer are urgently required. The exploration and preclinical evaluation of new treatments requires an animal tumor model that mimics the human counterpart. Animal models are key in bladder cancer research and provide a bridge to the clinic. Various animal bladder cancer models have been described to date, but the tumor take rate is reported to be 30-100%. Establishment of reliable, simple, practicable and reproducible animal models remains an ongoing challenge. The present review summarizes the latest developments with regard to the establishment of animal models and tumor evaluation.

References

Sep 1, 1985·The Journal of Clinical Investigation·L A SpryB B Davis
Jan 1, 1997·Urological Research·F Jiang, X M Zhou
Jun 13, 2002·International Journal of Urology : Official Journal of the Japanese Urological Association·Jun CheonChinghai Kao
Jan 14, 2003·Seminars in Cell & Developmental Biology·David C Rubinsztein
Jul 26, 2005·Urology·Minoru HorinagaWilliam Larchian
May 12, 2006·Nature·John L LangowskiMartin Oft
Jun 13, 2006·Urology·Aimee M JohnsonJay E Reeder
Nov 18, 2006·Toxicology and Applied Pharmacology·Samuel M CohenX Chris Le
May 19, 2007·The Journal of Urology·Eric B SmithDouglas S Scherr
Aug 30, 2007·Cancer Metastasis Reviews·Peter C Black, Colin P N Dinney
Dec 25, 2007·Journal of Immunotherapy·Sara M MangsboThomas H Tötterman
Aug 2, 2008·Neoplasia : an International Journal for Oncology Research·Paul D WilliamsDan Theodorescu
Feb 14, 2009·World Journal of Urology·Leonardo Oliveira ReisUbirajara Ferreira
Apr 25, 2009·BJU International·Eddie ChanWilliam Larchian
Jun 23, 2009·The Journal of Urology·Catalina LodillinskyAna María Eiján
Jul 1, 2009·The Journal of Experimental Medicine·Lin WangHua Yu
Dec 9, 2010·Nature Reviews. Urology·Guido Dalbagni
Dec 21, 2010·Neoplasia : an International Journal for Oncology Research·Zhong WuDan Theodorescu
Feb 23, 2011·Journal of Visualized Experiments : JoVE·Georgina L Dobek, W T Godbey
Mar 17, 2012·Disease Models & Mechanisms·Imran AhmadHing Y Leung
Aug 11, 2012·European Urology·Maximilian BurgerYair Lotan
Mar 15, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayF Bray
Jul 6, 2013·European Urology·Marko BabjukUNKNOWN European Association of Urology
Oct 30, 2013·Molecular Medicine·Petros D GrivasMark L Day
Jun 13, 2014·International Journal of Cancer. Journal International Du Cancer·Colleen WebberPatti A Groome

❮ Previous
Next ❯

Citations

Nov 2, 2017·Nature Reviews. Urology·Richard C WalshawAnanya Choudhury
May 8, 2018·Bladder Cancer·Tahlita C M ZuiverloonDan Theodorescu
Mar 15, 2019·Oncology Letters·Marina AlbertóValeria Inés Segatori

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
xenograft
bioluminescence
scraping
xenografts

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.